Cohance Lifesciences Limited — Updates, 05-08-2026: General Updates
05-08-2026 | 06:43 pm
05-08-2026 | 06:43 pm
Cohance Lifesciences' USFDA inspection at its Hyderabad facility concluded with five observations. Importantly, none relate to data integrity issues. The company is preparing corrective actions and expects timely resolution of these observations.
No comments yet. Be the first to comment!
